Skip to main content

Table 3 Associations of vascular measurements (FMD, NMD and PWV) with categorical parameters

From: Determinants of vascular function in patients with type 2 diabetes

 

FMD, %

P

NMD, %

P

PWV, m/sec

P

Gender

Male, n = 49

1.92 ± 1.56

 

10.32 ± 4.52

 

10.62 ± 2.54

 

Female, n = 116

2.00 ± 1.71

0.772

9.99 ± 3.51

0.648

10.02 ± 2.09

0.181

Smoking

Yes, n = 28

2.01 ± 1.47

 

10.33 ± 4.07

 

10.31 ± 2.58

 

No, n = 137

1.97 ± 1.70

0.900

10.04 ± 3.80

0.720

10.16 ± 2.18

0.793

Hypertension

Yes, n = 131

1.93 ± 1.65

 

9.58 ± 3.58

 

10.47 ± 2.24

 

No, n = 34

2.14 ± 1.73

0.528

12.05 ± 4.19

0.001

9.25 ± 1.98

0.009

Antihypertensive medications

Yes, n = 109

1.84 ± 1.64

 

9.09 ± 3.33

 

10.54 ± 2.12

 

No, n = 56

2.24 ± 1.68

0.143

12.03 ± 4.05

<0.001

9.57 ± 2.31

0.019

Hypercholesterolemia

Yes, n = 150

1.94 ± 1.65

 

10.03 ± 3.86

 

10.19 ± 2.24

 

No, n = 15

2.29 ± 1.77

0.441

10.63 ± 3.66

0.565

10.11 ± 2.23

0.911

Statins

Yes, n = 48

1.99 ± 1.65

 

9.88 ± 3.91

 

10.57 ± 2.45

 

No, n = 117

1.97 ± 1.67

0.951

10.17 ± 3.82

0.656

10.01 ± 2.12

0.199

Insulin treatment

Yes, n = 36

1.53 ± 1.66

 

8.65 ± 3.01

 

11.12 ± 2.72

 

No, n = 129

2.10 ± 1.65

0.066

10.49 ± 3.95

0.004

9.97 ± 2.06

0.059

  1. FMD, flow-mediated dilation of the brachial artery; NMD, nitrate-mediated dilation of the brachial artery; PWV, carotid-femoral pulse wave velocity.